[1] Siegel R L, Miller K D, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1):7
[2] Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115
[3] Khorana A A, Mangu P B, Berlin J, et al. Potentially curable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline[J]. J Clin Oncol, 2016, 34(21):2541
[4] Winter J M, Brennan M F, Tang L H, et al. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades[J]. Ann Surg Oncol,2012,19(1):169.
[5] Kamisawa T, Wood L D, Itoi T, et al. Pancreatic cancer[J]. Lancet, 2016, 388(10039):73
[6] Templeton A J, Mcnamara M G, ?譒eruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis[J]. J Natl Cancer Inst, 2014, 106(6):dju124
[7] Ippei M, Yoshiaki M, Makoto S, et al. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection:a multi-center retrospective study[J]. Pancreatology, 2015, 15(6):674
[8] 王卓,刘德军,霍砚淼,等.淋巴结转移对胰腺癌患者生存期的影响[J].中华肝胆外科杂志, 2016, 22(10):672
[9] Cheng P, Jin G, Hu X, et al. Analysis of tumor-induced lymphangiogenesis and lymphatic vessel invasion of pancreatic carcinoma in the peripheral nerve plexus[J]. Cancer Sci, 2012, 103(10):1756
[10] Teramukai S, Kitano T, Kishida Y A, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03[J]. Eur J Cancer, 2009, 45(11):1950
[11] Bausch D, Pausch T, Krauss T, et al. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic Switch in pancreatic ductal adenocarcinoma[J]. Angiogenesis, 2011, 14(3):235
[12] Gaida M M, Steffen T G, Günther F, et al. Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors[J]. Eur J Immunol, 2012, 42(12):3369
[13] Grosse-Steffen T, Giese T, Giese N, et al. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase[J]. Clin Dev Immunol, 2012, 2012:720768
[14] Coffelt S B, Kersten K, Doornebal C W, et al. IL-17-producing gamma delta T cells and neutrophils conspire to promote breast cancer metastasis[J]. Nature, 2015, 522(7556):345
[15] Fogar P, Sperti C, Basso D, et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome[J]. Pancreas, 2006, 32(1):22
[16] Chang J H, Jiang Y, Pillarisetty V G. Role of immune cells in pancreatic cancer from bench to clinical application: An updated review[J]. Medicine (Baltimore), 2016, 95(49):e5541
[17] Szkandera J, Stotz M, Eisner F, et al. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients[J]. PLoS One, 2013, 8(11):e78225
[18] Zhou Y, Wei Q, Fan J, et al. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients[J]. Clin Chim Acta, 2018, 479:181
[19] Stotz M, Gerger A, Eisner F, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer[J]. Br J Cancer, 2013, 109(2):416
[1]贾成玮,王荔,杨虎,等.NLR和PLR对腹膜透析患者腹膜炎的预测价值[J].天津医科大学学报,2023,29(02):183.
JIA Cheng-wei,WANG Li,YANG Hu,et al.Predictive value of NLR and PLR for peritonitis in peritoneal dialysis patients[J].Journal of Tianjin Medical University,2023,29(03):183.